Evidence map›Paper›PMID 11093254›Full record

ArticleCell motility and the cytoskeleton2000

VASP protects actin filaments from gelsolin: an in vitro study with implications for platelet actin reorganizations.

E L Bearer, J M Prakash, R D Manchester, P G Allen

Abstract read
In one paragraph

Article in Cell motility and the cytoskeleton, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  9. Article
  10. Article
  11. How VASP enhances actin-based motility.The Journal of cell biology · 2003
    Article
  12. Article
  13. Article
  14. Article
  15. Actin dynamics in platelets.International review of cytology · 2002
    Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

E L BearerDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912, USA. Elaine_Bearer@Brown.edu
J M Prakash
R D Manchester
P G Allen
Brown University · USHarvard University · US

Funding

MOLECULAR MECHANISMS OF ACTIN DYNAMICS IN PLATELETSR01GM047368 · NIGMS · BROWN UNIVERSITY · PI BEARER, ELAINE L · 1994 to 2003
$1.2M
CELL BIOLOGY AND BIOCHEMISTRY OF ACTIN SEVERING PROTEINSR01GM057256 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ALLEN, PHILIP G · 1999 to 2003
$917k
NIGMS NIH HHS GM47368NIGMS NIH HHS GM57256NIGMS NIH HHS R01 GM047368NIGMS NIH HHS R01 GM057256
6 · The paper itself

Abstract

An initial step in platelet shape change is disassembly of actin filaments, which are then reorganized into new actin structures, including filopodia and lamellipodia. This disassembly is thought to be mediated primarily by gelsolin, an abundant actin filament-severing protein in platelets. Shape change is inhibited by VASP, another abundant actin-binding protein. Paradoxically, in vitro VASP enhances formation of actin filaments and bundles them, activities that would be expected to increase shape change, not inhibit it. We hypothesized that VASP might inhibit shape change by stabilizing filaments and preventing their disassembly by gelsolin. Such activity would explain VASP's known physiological role. Here, we test this hypothesis in vitro using either purified recombinant or endogenous platelet VASP by fluorescence microscopy and biochemical assays. VASP inhibited gelsolin's ability to disassemble actin filaments in a dose-dependent fashion. Inhibition was detectable at the low VASP:actin ratio found inside the platelet (1:40 VASP:actin). Gelsolin bound to VASP-actin filaments at least as well as to actin alone. VASP inhibited gelsolin-induced nucleation at higher concentrations (1:5 VASP:actin ratios). VASP's affinity for actin (K(d) approximately 0.07 microM) and its ability to promote polymerization (1:20 VASP actin ratio) were greater with Ca(++)-actin than with Mg(++)-actin (K(d) approximately 1 microM and 1:1 VASP), regardless of the presence of gelsolin. By immunofluorescence, VASP and gelsolin co-localized in the filopodia and lamellipodia of platelets spreading on glass, suggesting that these in vitro interactions could take place within the cell as well. We conclude that VASP stabilizes actin filaments to the severing effects of gelsolin but does not inhibit gelsolin from binding to the filaments. These results suggest a new concept for actin dynamics inside cells: that bundling proteins protect the actin superstructure from disassembly by severing, thereby preserving the integrity of the cytoskeleton.

Indexed as

ActinsBlood PlateletsCalciumCell Adhesion MoleculesCell NucleusCytoskeletonDose-Response Relationship, DrugElectrophoresis, Polyacrylamide GelGelsolinHumansKineticsListeriaMagnesiumMicrofilament ProteinsMicroscopy, FluorescenceModels, BiologicalActinsCalciumCell Adhesion MoleculesGelsolinMagnesiumMicrofilament ProteinsPeptidesPhosphoproteinspolyprolineVasodilator-Stimulated Phosphoprotein

Identifiers

PMID11093254
PMCPMC3376085
OpenAlexW2103431046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.